ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2011, Vol. 20 ›› Issue (3): 227-234.

• 论文 • 上一篇    下一篇

血液透析患者死亡原因分析

  

  • 出版日期:2011-06-30 发布日期:2011-08-08

Analysis of the death cause in patients treated with hemodialysis

  • Online:2011-06-30 Published:2011-08-08

摘要:

目的:分析血液透析(hemodialysis,HD)患者的死亡原因,探讨影响生存的相关危险因素,为提高HD患者生存率提供依据。  方法:分析1998.1.1~2008.12.31HD死亡患者的临床资料,分析其死亡原因。  结果:同期HD患者共811例,死亡237例,死亡患者透始中位年龄67(19~87)岁,男性占60.8%,中位生存时间9.6(0.1~96.6)月。主要死因为心血管疾病(20.3%)、脑血管疾病(16.5%)、感染(24.9%)。与非心脑血管疾病死因患者相比,死于心脑血管疾病的HD患者女性比例(43.8% vs 38.1%,P<0.05)、原发病为糖尿病肾病的比例(25.0% vs 11.1%,P<0.05)、HD前有左室肥厚史的比例(13.9% vs 4.9%,P<0.05)、充血性心衰病史的比例(33.3% vs 13.4%,P<0.05)显著较高,BMI(20.9 kg/m2 vs 23.7 kg/m2,P<0.05)、eGFR(6.67 ml/min•1.72m2 vs 9.53 ml/min•1.72m2,P<0.05)显著较低。Logistic回归分析提示BMI较低、透前有充血性心衰史和左室肥厚史是HD患者死因为心血管疾病的危险因素。瑟非感染死因患者相比,死于感染的HD患者透始年龄显著较大(66岁vs 62岁,P<0.05)、透前血白蛋白显著较低(30.2g/L vs 33.1g/L,P<0.05)。Logistic回归分析提示透始年龄大、透前低白蛋白是HD患者死因为感染的危险因素。33.3%患者于HD开始3月内死亡,其主要死亡原因为感染(38.0%)、心血管疾病(22.8%)、脑血管疾病(11.4%)。HD开始3月内死亡患者的慢性肾小球肾炎比例(20.6% vs 36.2%,P<0.05)、透前血钙(1.91mmol/L vs 2.18mmol/L,P<0.05)、血白蛋白(29.2g/L vs 34.7g/L,P<0.05)、CO2-CP(18.52mmol/L vs 22.15mmol/L,P<0.05)、eGFR(7.55ml/min•1.72m2 vs 10.29 ml/min•1.72m2,P<0.05)均显著较低,HD前有充血性心衰病史的比例(19.4%,16.3%,P<0.05)、Charlson并发症指数(CCI)=5-10的比例(25.4% vs 13.5%,P<0.05)显著较高。Logistic回归分析提示透前低白蛋白血症、eGFR较低、有充血性心衰史、CCI≥5是HD患者3月内死亡的危险因素。  结论:HD患者主要死亡原因为心、脑血管疾病和感染。在HD开始3月内死亡风险较高,尤其是透前血白蛋白较低、有充血性心衰病史、CCI≥5和开始透析时机较晚的患者。积极改善患者的营养状况、防治心脑血管疾病、感染等合并症或并发症、适当提早HD可能有助于提高患者的早期生存率。

关键词: 血液透析,死亡,心血管并发症, 感染,早期生存率

Abstract:

Objective: To analyze the death causes in patients with hemodialysis, explore the risk factors affecting survival and provide some way to improve the survival of hemodialysis patients. Methodology: The causes of death in patients with hemodialysis were retrospectively analyzed during the periods Jan. 1998 to Dec. 2008.  Results: Two hundred and thirty seven cases in total eighty hundred eleven hemodialysis patients were died in the study period. Their average age at the beginning of hemodialysis was 63 (19 to 87) years old and men accounted for 60.8%. The median survival time was 9.6 (0.1 to 96.6) months. The main causes of death in our patients were cardiovascular disease (20.3%), infection (24.9%) and cerebrovascular disease (16.5%). [The proportion of females (43.7% vs 36.7%, P<0.05) and diabetic nephropathy as the underlying disease (25.0% vs 11.1%, P<0.05) was significantly higher and more patients had the history of left ventricular hypertrophy (9.6% vs 4.7%, P<0.05) and congestive heart failure (23.3% vs 13.4%, P<0.05) before hemodialysis in patients died due to cardiovascular and cerebrovascular diseases whose BMI (21.1 vs 23.6 kg/m2, P<0.05) and eGFR (7.6 vs 10.0 ml/min•1.72m2, P<0.05) before hemodialysis were lower]. Logistic regression analysis revealed that lower BMI, the history of left ventricular hypertrophy and congestive heart failure before hemodialysis were the risk factors of dying due to cardiovascular and cerebrovascular diseases. The patients died from infection were older (66 vs 62 years old, P<0.05) and their blood albumin before hemodialysis was lower (30.2 vs 33.1g/L, P<0.05). Logistic regression analysis showed that older patients, lower blood albumin before hemodialysis were the risk factors of dying from infection. 33.3 percent of the all deaths died within 3 months of hemodialysis.The main causes of death were infection (38.0%), cardiovascular diseas e(22.8%) and cerebrovascular disease (11.4%) in patients died within 3 months of hemodialysis. The proportion of chronic glomerulonephritis(CGN) as underlying disease was significantly lower (20.6% vs 36.2%, P<0.05). More patients had the history of congestive heart failure (19.4% vs 16.3%, P<0.05) and Charlson comorbidity index (CCI) =5-10 before hemodialysis in patients died within 3 months of hemodialysis and their blood calcium(1.91 vs 2.18mmol/L, P<0.05), blood albumin (29.2 vs 34.7g/L, P<0.05) and eGFR (7.55 vs 10.29 ml/min•1.72m2, P<0.05) before hemodialysis was significantly lower. Logistic regression analysis showed that lower blood albumin, lower eGFR, the history of congestive heart failure and CCI≥5 before hemodialysis were the risk factors of dying within 3 months of hemodialysis. Conclusion: Cardiovascular and cerebrovascular diseases, infection are the main causes of death in hemodialysis patients. There is a higher risk of death within 3 months of hemodialysis especially in patients whose blood albumin is lower, CCI≥5 and who have the history of congestive heart failure before hemodialysis and start hemodialysis late. Improvement of the nutritional status of patients, prevention and treatment of cardiovascular and cerebrovascular diseases and infection complications of hemodialysis and starting hemodialysis early properly should be emphasized to improve the early survival of hemodialysis.